Tandem Diabetes Care Inc
TNDM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.33B
Close$
$-3.33
117.5% downside
Current Fair Value
117.5% downsideOvervalued by 117.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.33 Billion |
|---|---|
| Enterprise Value | $2.01 Billion |
| Earnings per Share | $-3.04 |
| Beta | 1.66 |
| Outstanding Shares | 68,397,000 |
Return
| Return on Equity | -48.56% |
|---|---|
| Return on Assets | -5.49% |
| Return on Invested Capital | -5.57% |
Valuation & Multiples
| P/E Ratio | -20.58 |
|---|---|
| PEG | 34.52 |
| Price to Sales | 1.27 |
| Price to Book Ratio | 19.05 |
| Enterprise Value to Revenue | 1.93 |
| Enterprise Value to EBIT | -40.12 |
| Enterprise Value to Net Income | -32 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 5.73 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$-0.24
Consensus analyst estimateRevenue Estimate
$266.12 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 8.05% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.55%▼ 111.53% |
|---|---|
| Total Invested | $51.49M▼ 95.70% |
| Investors Holding | 57▼ 233.00% |
About Tandem Diabetes Care Inc
1,600 employees
CEO: John Sheridan
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach t...